# Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

> **NCT00735397** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 1218 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** perampanel

## Key facts

- **NCT ID:** NCT00735397
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 1218 (ACTUAL)
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735397, "Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00735397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*